Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers...
3-Jun-2019 7:30 AM EDT Add to Favorites

New Technique by Yale Cancer Center Scientists May Improve Detection and Treatment of Advanced Brain Cancer

In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they metastasize to the brain.
29-Apr-2019 8:00 AM EDT Add to Favorites

Smilow Cancer Hospital and Yale Cancer Center receive grant from Frederick A. DeLuca Foundation to fund Hematology Research Center

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) are proud to announce a five-year grant awarded by The Frederick A. DeLuca Foundation to establish The DeLuca Center for Innovation in Hematology Research.
24-Apr-2019 12:30 PM EDT Add to Favorites

Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy

One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients...
28-Mar-2019 1:05 PM EDT Add to Favorites

Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.
19-Feb-2019 2:20 PM EST Add to Favorites

Yale Cancer Center scientists advise caution in immunotherapy research

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new...
19-Dec-2018 12:05 PM EST Add to Favorites

Yale Cancer Center scientists show immunotherapy drug can help patients with metastatic melanoma

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful...
8-Nov-2018 11:05 AM EST Add to Favorites

Yale Cancer Center Finds Patients Choose Cancer Care Based on Hospital Affiliations

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.
7-Nov-2018 9:30 AM EST Add to Favorites

see all news